Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Next Day Early Morning Growth Hormone as Predictor of Pituitary Function After Transsphenoidal Adenomectomy

NCT03708523 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT03708523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03708523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Next Day Early Morning Growth Hormone as Predictor of Pituitary Function After Transsphenoidal Adenomectomy
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Unknown status
Start date
November 1, 2018
Completion date
September 30, 2019
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypopituitarism